Your search returned 3 results. Subscribe to this search

|
1. Intermittent left bundle branch block and acute heart failure in trastuzumab-induced cardiotoxicity

by Masson, Ravi.

Published: 2020; ; ; Citation: BMJ Case Reports. 13(7), 2020 Jul 28.; .Institution: MedStar Washington Hospital Center.Department: Medicine/Internal Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Bakhshi H; Haddad TM; Masson R.UI/PMID: 32723779.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1136/bcr-2020-236009 (Click here)
2. Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831

by Swain, Sandra M.

Citation: Journal of Clinical Oncology. 32(33):3744-52, 2014 Nov 20..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't.Full author list: Perez EA; Romond EH; Suman VJ; Jeong JH; Sledge G; Geyer CE Jr; Martino S; Rastogi P; Gralow J; Swain SM; Winer EP; Colon-Otero G; Davidson NE; Mamounas E; Zujewski JA; Wolmark N.UI/PMID: 25332249.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1200/JCO.2014.55.5730 (Click here)
3. Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer

by Swain, Sandra M.

Citation: Journal of Clinical Oncology. 32(33):3753-61, 2014 Nov 20..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't.Full author list: Baselga J; Cortes J; Im SA; Clark E; Ross G; Kiermaier A; Swain SM.UI/PMID: 25332247.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1200/JCO.2013.54.5384 (Click here)

Powered by Koha